Pharmaceuticals - United Kingdom
Event -
Globalisation and technology are making the world a smaller place. As the interests of developed and developing countries converge, so do the interests of the different players in the healthcare sector across the world.
The Global Healthcare Summit will bring together senior decision-makers from across globe from the healthcare value...
Video -
Automotive Banking Business Technology Global Sport Central and Local government Insurance Defence Investment Management Energy, Resources, Materials Marketing Retail Financial Services Finance Innovation Operations Wealth Securities Strategy Food & Agriculture Health Care High Tech Nonprofit Pharmaceuticals Public Sector Retail & Consumer Goods Telecoms Media & Entertainment Transportation
Video -
Jonathan Sands, Elmwood on "rebranding pharma"
Event -
THE STRATEGIC EVENT FOR THE PHARMA INDUSTRY
The pharma industry is facing some difficult strategic choices. As the costs of R&D escalate, other more reliable revenue streams look increasingly attractive.
What are the best bets? Will big pharma in its current incarnation even be around in ten years time? And will it be new business models or...
Review -
The 17th Annual Pharma Summit took place in London on February 10th. With eight out of the world’s top ten pharmaceutical companies attending, and over 200 delegates, this was one of best pharma events yet.
With an impressive line-up of speakers from top pharma companies including AstraZeneca, Astellas Pharma, Novo Nordisk, Nycomed, Pfizer, and...
Review -
The Pharma Summit 2011: Reinventing Pharma for a New Generation took place on February 10th 2011 at The Dorchester, London. Over 200 senior pharma executives gathered to discuss how the pharma industry needs to rebuild its image and position itself as a key industry in tomorrow’s marketplace.
Key speakers included:• John Lechleiter,...
Video -
David Redfern, Chief Strategy Officer of GlaxoSmithKline, one of the world's biggest pharma companies, outlines his perspectives on current industry challenges with reference to GSK's strategy.
News -
"The global pharma industry is at a crossroads. On one hand, the weaknesses of the R&D pipeline and the demise of the blockbuster business model demand an end to business-as-usual. On the other hand, huge opportunities beckon, as the need for a robust and innovative drugs industry has never been greater.
Thanks to rising prosperity and...
News -
Today’s big pharma companies would have been almost unrecognisable ten years ago. No longer ableto rely on patented drugs for their revenue streams, they have been diversifying into new products—fromgenerics to animal health and consumer healthcare—and into new markets, especially the fast-growingAsian economies.
But is this trajectory sustainable...
